Bill > SB236

This bill requires the Public Employees Insurance Agency (PEIA), Medicaid, and other health insurance providers in West Virginia to cover intravenous immunoglobulin therapy for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, pediatric acute onset neuropsychiatric syndrome, and other autoimmune encephalopathies. However, the coverage is only provided if the insured's physician obtains prior authorization by demonstrating that all other treatments have been exhausted, and the requirements apply to plans issued or renewed after January 1, 2025.